Cargando…
Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
Extracellular vesicles (EVs) hold great promise for transporting CRISPR–Cas9 RNA-guided endonucleases (RNP) throughout the body. However, the cell-selective delivery of EVs is still a challenge. Here, we designed valency-controlled tetrahedral DNA nanostructures (TDNs) conjugated with DNA aptamer, a...
Autores principales: | Zhuang, Jialang, Tan, Jizhou, Wu, Chenglin, Zhang, Jie, Liu, Ting, Fan, Chunhai, Li, Jiaping, Zhang, Yuanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498310/ https://www.ncbi.nlm.nih.gov/pubmed/32810272 http://dx.doi.org/10.1093/nar/gkaa683 |
Ejemplares similares
-
CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
por: Lin-Shiao, Enrique, et al.
Publicado: (2022) -
Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014) -
Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022) -
CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids
por: Yang, Hui, et al.
Publicado: (2023) -
Cas1–Cas2 physically and functionally interacts with DnaK to modulate CRISPR Adaptation
por: Killelea, Tom, et al.
Publicado: (2023)